RAPP
Rapport Therapeutics Inc

398
Mkt Cap
$1.33B
Volume
415,302.00
52W High
$42.27
52W Low
$6.43
PE Ratio
-11.75
RAPP Fundamentals
Price
$28.93
Prev Close
$26.88
Open
$26.77
50D MA
$24.41
Beta
1.46
Avg. Volume
1.74M
EPS (Annual)
-$2.14
P/B
4.01
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal
Rapport Therapeutics stock jumps 62% in a week as mid-stage study of RAP-219 meets goals in drug-resistant epilepsy patients.
Zacks·2mo ago
News Placeholder
Rapport Therapeutics Stock Rockets 204% Pre-Market To Head Toward All-Time Highs – Here’s What Happened
The company said that it now plans to advance the investigational therapy into two late-stage trials in the third quarter of 2026.
Stocktwits·2mo ago

Latest RAPP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.